Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents. - Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM (Peptides, 2018)